Company Update: Pfizer Inc (NYSE:PFE) – Fitch Solutions: CDS Sentiment Souring for Pfizer, Improving for AstraZeneca

[Reuters] – Takeover speculation involving AstraZeneca Plc and Pfizer is leading to two very different sentiments with respect to credit default swap (CDS) spread movement, according to Fitch Solutions in its latest CDS . . . → Read More: Company Update: Pfizer Inc (NYSE:PFE) – Fitch Solutions: CDS Sentiment Souring for Pfizer, Improving for AstraZeneca Similar Articles: Market Update: Pfizer Inc (NYSE:PFE) – AstraZeneca rejects Pfizer’s raised bid of $106 bln Market Update (NYSE:PFE): Pfizer prepares sweeter bid for AstraZeneca – report Pfizer Inc (NYSE:PFE) – Pfizer chasing AstraZeneca for potential $100 bln deal